Eli Lilly - OFG Launch Event

About the Event

The HCP program on 6 November will mark the launch of FOUNDAYO™ (orforglipron) to healthcare professionals in the UAE. The program will include scientific and product-focused presentations, expert panel discussions and moderated conversations focused on the evolving treatment landscape for obesity and type 2 diabetes and the role of FOUNDAYO™ within clinical practice. Attendance will be restricted to eligible healthcare professionals. Invitations will be shared directly with HCPs through Emails, Healthcare Organizations, societies, and similar professional channels, with registration and access limited to verified HCPs. The HCP program will not be promoted through to the public through any media or public advertising. Day 2: Public cardiometabolic health education program The public program on 7 November will be a free-to-attend, public, in-person disease-state education event open to the general public residing in the UAE, focused on cardiometabolic health, including obesity and type 2 diabetes. As the two programs will be operated and communicated separately: no product branding will appear in any public-facing communication, registration page, on-site signage or content associated with the 7 November program, and public registration will be handled through a dedicated path separate from the HCP program. The program aims to: • Increase public awareness of cardiometabolic diseases, including obesity and type 2 diabetes • Encourage adults residing in the UAE to seek healthy lifestyle, empower healthy living, seek guidance from qualified healthcare providers • Support informed and proactive health-seeking behaviour The program will feature healthcare professionals and public influencers, with expert discussions and moderated conversations designed to provide accessible disease-state and general health education. The experience will also include educational activation stations before and after the main stage program. These will reinforce the event’s educational themes through interactive experiences focused on cardiometabolic health. No diagnostic assessment or collection of health data will form part of these activations. Public invitation and registration channels To build awareness and encourage participation for the 7 November summit, event communications will be shared through: • Event communications featuring international talents (Potential Talents: Steven Barlett, Fatima Kodi, etc) • 15+ licensed UAE-based influencers (including Karen Wazen, Anas Bukhash, Hadeel Marei, Kris Fade, and others) • Radio and media partnerships, including ARN Radio and Time Out Dubai • Pharmacy and Healthcare organizations partner’s own digital channels • Earned media outreach to UAE journalists and media • Paid digital media • Billboards Interested members of the public will be directed to the event website to register free of charge. Registration will collect only the information necessary to manage attendance, processed in accordance with applicable UAE data protection law through a third party where Lilly will not have access to the personal information submitted. All public-facing communications will relate solely to the disease state education program and will be developed in line with MOHAP requirements for public health communication and submitted to MOHAP for approval prior to publication or release, as required. No products, brands therapeutic options, or medical advice will be named, promoted or referenced in any public-facing communications or content. DTCM Permit + Ticketing